Is AI coming for my job? It’s not uncommon to wonder these days. 

What if AI could just read a press release and appreciate the value of a stock at least as well as I think I can? Might not be a big jump from there to AI opening up its own biotech fund. 

But before I ceded my job to ChatGPT, I figured I would at least take it for a test drive by having it analyze a press release from a company I knew well.

There is a real and urgent need for better flu prophylaxis and therapeutics. RA Managing Director Laura Tadvalkar writes about why RA is excited to lead a transformative transaction that returns a long-acting antiviral for flu to its original developer Cidara, and RA’s new initiative to help make outlicensing from pharma companies faster and more efficient.